Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06160427 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Connective Tissue Matrix for Rotator Cuff Tendinopathy

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Secondary endpoints revised (12)
    • Site details revised at 4 of 4 sites
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 3 to 4
    • Start date changed from estimate of Jan 15, 2024 to Dec 4, 2023
    • Study title shortened, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.
Trial Details
NCT Number NCT06160427
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborators: Connective Tissue Matrix Biomedical, LLC
Conditions
(from sponsor)		 Tendinopathy, Shoulder Pain, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis
Related terms Rotator Cuff Injuries, Shoulder Pain, Tendinopathy
Enrollment 92 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov